PubRank

Hiroyuki Daida

Author PubWeight™ 206.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Red blood cell distribution width as an effective tool for detecting fatal heart failure in super-elderly patients. Intern Med 2012 2.19
2 Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009 2.08
3 Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol 2005 1.97
4 Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004 1.89
5 Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009 1.80
6 Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2006 1.72
7 Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007 1.70
8 Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ J 2011 1.62
9 Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Circ J 2010 1.58
10 Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005 1.56
11 Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J). Circ J 2011 1.54
12 Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circ J 2011 1.53
13 Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: the lower, the better; is it true for Asians? (Pro). Circ J 2010 1.51
14 Prevalence and clinical implication of metabolic syndrome in chronic heart failure. Circ J 2010 1.51
15 Ventricular fibrillation refractory to ICD therapy. Intern Med 2005 1.50
16 Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. Circ J 2010 1.49
17 Candesartan with pioglitazone protects against endothelial dysfunction and inflammatory responses in porcine coronary arteries implanted with sirolimus-eluting stents. Circ J 2011 1.47
18 Probucol therapy improves long-term (>10-year) survival after complete revascularization: a propensity analysis. Atherosclerosis 2011 1.47
19 Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention. Hypertens Res 2008 1.46
20 Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent. J Card Surg 2012 1.46
21 Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J 2011 1.45
22 Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007 1.45
23 Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study. Circ J 2012 1.45
24 Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb 2013 1.42
25 The impact of pravastatin therapy on long-term outcome in patients with metabolic syndrome undergoing complete coronary revascularization. Circ J 2009 1.41
26 Appropriate Level of Low-Density Lipoprotein Cholesterol for Secondary Prevention of Coronary Artery Disease. J Atheroscler Thromb 2015 1.41
27 Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study. Circ J 2012 1.40
28 Effects of Phase II Comprehensive Cardiac Rehabilitation on Coronary Plaque Volume After Acute Coronary Syndrome. Int Heart J 2015 1.40
29 Prognostic Impacts of Metabolic Syndrome in Patients With Chronic Heart Failure　- A Multicenter Prospective Cohort Study. Circ J 2016 1.39
30 Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. Int Heart J 2017 1.39
31 Prognostic significance of glomerular filtration rate estimated by the Japanese equation among patients who underwent complete coronary revascularization. Hypertens Res 2010 1.39
32 Synergistic effects of calcium-channel and angiotensin-receptor blockers on endothelial function and inflammatory responses in a porcine drug-eluting stent model. Circ J 2010 1.39
33 Safety of exercise-based cardiac rehabilitation and exercise testing for cardiac patients in Japan: a nationwide survey. Circ J 2014 1.39
34 Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003 1.33
35 Wavering calcified amorphous tumour of the heart in a haemodialysis patient. Interact Cardiovasc Thorac Surg 2012 1.19
36 Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb 2010 1.10
37 Adiponectin and atherosclerotic disease. Clin Chim Acta 2004 1.08
38 Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 2003 1.07
39 Metabolic syndrome. J Atheroscler Thromb 2008 1.06
40 Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -. Circ J 2010 1.03
41 Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J Biol Chem 2009 1.03
42 A murmur-free giant myxoma discovered incidentally on abdominal ultrasonography. Intern Med 2013 1.02
43 Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT). Cardiovasc Diabetol 2011 1.02
44 Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism. J Biol Chem 2011 1.00
45 Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J 2012 0.99
46 More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. J Atheroscler Thromb 2010 0.99
47 Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol 2013 0.99
48 Infective endocarditis with Lactococcus garvieae in Japan: a case report. J Med Case Rep 2011 0.96
49 Gender-based outcomes among patients with diabetes mellitus after percutaneous coronary intervention in the drug-eluting stent era. Int Heart J 2011 0.95
50 Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. PLoS One 2012 0.95
51 Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 2004 0.95
52 Age-dependent clinical characteristics of micturition syncope. Circ J 2009 0.95
53 Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease. Int J Vasc Med 2012 0.95
54 Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. J Atheroscler Thromb 2010 0.94
55 Beneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study. J Cardiol 2008 0.94
56 Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study. Cardiovasc Diabetol 2012 0.94
57 Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model. Circ J 2008 0.94
58 Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb 2007 0.92
59 Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome. Atherosclerosis 2011 0.92
60 Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models. Atherosclerosis 2005 0.92
61 Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 2010 0.91
62 Familial hypercholesterolemia. J Atheroscler Thromb 2013 0.91
63 Different responses to oxidized low-density lipoproteins in human polarized macrophages. Lipids Health Dis 2011 0.91
64 Effects of phase III cardiac rehabilitation programs on health-related quality of life in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circ J 2003 0.90
65 Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Atherosclerosis 2004 0.90
66 Relationship between exercise tolerance and muscle strength following cardiac rehabilitation: comparison of patients after cardiac surgery and patients with myocardial infarction. J Cardiol 2009 0.90
67 Takotsubo cardiomyopathy associated with epilepsy complicated with giant thrombus. Int J Cardiol 2009 0.89
68 Poor implementation of cardiac rehabilitation despite broad dissemination of coronary interventions for acute myocardial infarction in Japan: a nationwide survey. Circ J 2007 0.89
69 Circadian, weekly, and seasonal variation at the onset of acute aortic dissection. Am J Cardiol 2002 0.89
70 Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Hum Gene Ther 2005 0.89
71 Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy. Int J Cardiol 2006 0.89
72 Influence of diabetes on >10-year outcomes after percutaneous coronary intervention. Heart Vessels 2008 0.88
73 Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009 0.88
74 Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2013 0.88
75 Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. Curr Med Res Opin 2009 0.88
76 Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. Biochem Biophys Res Commun 2008 0.88
77 Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J Biol Chem 2011 0.88
78 Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012. J Atheroscler Thromb 2013 0.88
79 Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis 2010 0.88
80 Presence of alpha-smooth muscle actin-positive endothelial cells in the luminal surface of adult aorta. Biochem Biophys Res Commun 2009 0.88
81 Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome. Atherosclerosis 2013 0.87
82 Global longitudinal strain in relation to the severity of aortic stenosis: a two-dimensional speckle-tracking study. Echocardiography 2011 0.87
83 Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension study. Circ J 2013 0.87
84 Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol. Heart Vessels 2013 0.87
85 Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care 2004 0.86
86 Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.86
87 Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study. Int Heart J 2013 0.86
88 Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. Circulation 2004 0.86
89 Sinus node dysfunction concomitant with Brugada syndrome. Circ J 2005 0.86
90 Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006 0.86
91 Goals of dyslipidemia management. J Atheroscler Thromb 2007 0.85
92 Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 2008 0.85
93 Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy. PLoS One 2012 0.85
94 Platelets activated by collagen through the immunoreceptor tyrosine-based activation motif in the Fc receptor gamma-chain play a pivotal role in the development of myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2005 0.85
95 Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol 2013 0.85
96 Deletion of the Fc receptors gamma chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet. Cardiovasc Res 2008 0.85
97 Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice. J Atheroscler Thromb 2010 0.85
98 Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J 2009 0.85
99 Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009 0.85
100 Angina pectoris with pharyngeal pain alone: a case report. Angiology 2008 0.84
101 Aberrant cell-to-cell coupling in Ca2+-overloaded guinea pig ventricular muscles. Am J Physiol Cell Physiol 2008 0.84
102 Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. Clin Chim Acta 2011 0.84
103 The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease. Atherosclerosis 2007 0.83
104 Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury. Circulation 2002 0.83
105 Triggers and circadian distribution of the onset of acute aortic dissection. Circ J 2002 0.83
106 R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J Atheroscler Thromb 2003 0.83
107 Clinical factors associated with classical symptoms of aortic valve stenosis. J Heart Valve Dis 2013 0.83
108 Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. J Atheroscler Thromb 2013 0.83
109 Serum uric Acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease. Int Heart J 2007 0.83
110 Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis 2008 0.83
111 Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circ J 2008 0.83
112 A Japanese case of familial cardiac myxoma associated with a mutation of the PRKAR1alpha gene. Intern Med 2005 0.83
113 Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. J Cardiol 2008 0.82
114 Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation. Circ J 2015 0.82
115 Red blood cell distribution width for heart failure. Intern Med 2013 0.82
116 Usefulness of running wheel for detection of congestive heart failure in dilated cardiomyopathy mouse model. PLoS One 2013 0.82
117 Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome. J Cardiol 2012 0.82
118 High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men. Diabetes Res Clin Pract 2008 0.82
119 Diagnostic criteria for dyslipidemia. J Atheroscler Thromb 2013 0.82
120 Treatment - therapeutic lifestyle modification. J Atheroscler Thromb 2008 0.82
121 Association of low glomerular filtration rate with the incidence of stroke in patients following complete coronary revascularization. Circ J 2011 0.82
122 Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. Circ J 2013 0.82
123 Brugada-like precordial ST elevation on ECG by anterior mediastinal infective mass lesion. Indian Pacing Electrophysiol J 2003 0.82
124 Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 2006 0.82
125 Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.82
126 Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.81
127 Behavior of Ca(2+) waves in multicellular preparations from guinea pig ventricle. Am J Physiol Cell Physiol 2004 0.81
128 Impact of physical activity on cardiovascular events in patients with chronic heart failure. A multicenter prospective cohort study. Circ J 2013 0.81
129 One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry. J Stroke Cerebrovasc Dis 2012 0.81
130 Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting. Atherosclerosis 2007 0.81
131 Mortality risk of triglyceride levels in patients with coronary artery disease. Heart 2012 0.81
132 Transbrachial intra-aortic balloon pumping for a patient with fulminant myocarditis. Heart Vessels 2012 0.81
133 Temporal Trends in Clinical Outcome After Percutaneous Coronary Intervention 1984-2010　- Report From the Juntendo PCI Registry. Circ J 2015 0.81
134 Ventricular fibrillation induced by short-long-short sequence during managed ventricular pacing. J Cardiovasc Electrophysiol 2011 0.81
135 Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1. Hypertens Res 2009 0.81
136 Adherence to preferable behavior for lipid control by high-risk dyslipidemic Japanese patients under pravastatin treatment: the APPROACH-J study. J Atheroscler Thromb 2012 0.81
137 Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Nephrol Dial Transplant 2011 0.81
138 Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits. Atherosclerosis 2002 0.81
139 Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study. Int Heart J 2014 0.81
140 Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. J Atheroscler Thromb 2013 0.81
141 Impact of diabetes on muscle mass, muscle strength, and exercise tolerance in patients after coronary artery bypass grafting. J Cardiol 2011 0.80
142 Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Atherosclerosis 2010 0.80
143 Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial. Atherosclerosis 2011 0.80
144 Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting. J Cardiol 2009 0.80
145 Dynamin-2 regulates oxidized low-density lipoprotein-induced apoptosis of vascular smooth muscle cell. Circulation 2004 0.80
146 High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. Diabetes Res Clin Pract 2012 0.80
147 Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome. Clin Chim Acta 2011 0.80
148 Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes. Circ J 2012 0.80
149 Insulin response to oral glucose load is associated with coronary artery disease in subjects with normal glucose tolerance. J Atheroscler Thromb 2008 0.80
150 Causes of abnormal Ca2+ transients in Guinea pig pathophysiological ventricular muscle revealed by Ca2+ and action potential imaging at cellular level. PLoS One 2009 0.80
151 Usefulness of prominently projected aortic arch on chest radiograph to predict severe tortuosity of the right subclavian or brachiocephalic artery in patients aged >44 years undergoing coronary angiography with a right radial artery approach. Am J Cardiol 2012 0.80
152 Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group. Jpn J Radiol 2013 0.80
153 A modified Essen stroke risk score for predicting recurrent cardiovascular events: development and validation. Int J Stroke 2012 0.79
154 Enhanced accumulation of adipocytes in bone marrow stromal cells in the presence of increased extracellular and intracellular [Ca²⁺]. Biochem Biophys Res Commun 2012 0.79
155 Prediction of coronary artery stenosis at rest in patients with normal left ventricular wall motion. Segmental analyses using strain imaging diastolic index. Int Heart J 2013 0.79
156 Clinical characteristics of defecation syncope compared with micturition syncope. Circ J 2009 0.79
157 Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders. Expert Rev Cardiovasc Ther 2014 0.79
158 Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting. Int J Cardiol 2004 0.79
159 Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial. Ther Apher Dial 2006 0.79
160 Waon Therapy for Managing Chronic Heart Failure　- Results From a Multicenter Prospective Randomized WAON-CHF Study. Circ J 2016 0.78
161 Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter. Circ J 2006 0.78
162 Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.78
163 Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome. Int Heart J 2011 0.78
164 Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes. PLoS One 2013 0.78
165 The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization. J Hypertens 2009 0.78
166 Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group. Clin Exp Nephrol 2013 0.78
167 Japanese features of native valve endocarditis caused by coagulase-negative staphylococci: case reports and a literature review. Intern Med 2013 0.78
168 [Change of concept and pathophysiology in acute coronary syndrome]. Nihon Rinsho 2010 0.78
169 Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome. J Cardiol 2012 0.78
170 Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period. Atherosclerosis 2009 0.78
171 T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents? Eur Heart J 2006 0.78
172 Dipyridamole therapy improves long-term survival after complete revascularization in patients with impaired cardiac function: a propensity analysis. Circ J 2008 0.78
173 Interleukin-1 receptor antagonist originating from bone marrowderived cells and non-bone marrow-derived cells helps to suppress arterial inflammation and reduce neointimal formation after injury. J Atheroscler Thromb 2014 0.78
174 Clinical impact of angiographic restenosis after bare-metal stent implantation on long-term outcomes in patients with coronary artery disease. Circ J 2011 0.78
175 Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.78
176 Primary right atrial cardiac osteosarcoma with congestive heart failure. Eur J Cardiothorac Surg 2009 0.78
177 Long-term outcomes of women with coronary artery disease following complete coronary revascularization. J Cardiol 2011 0.78
178 Rationale and design of the EPISTEME trial: efficacy of post-stroke intensive rosuvastatin treatment for aortogenic embolic stroke. Cardiovasc Drugs Ther 2014 0.78
179 A novel method for non-invasive plaque morphology analysis by coronary computed tomography angiography. Int J Cardiovasc Imaging 2014 0.77
180 Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006 0.77
181 Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. Atherosclerosis 2009 0.77
182 Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients. Clin Biochem 2012 0.77
183 Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome. J Atheroscler Thromb 2016 0.77
184 Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects). Circ J 2007 0.77
185 Altered breathing syndrome in heart failure: newer insights and treatment options. Curr Heart Fail Rep 2015 0.77
186 Relationship between coronary artery wall thickness measured by 64-slice multidetector computed tomography and cardiovascular risk factors. Circ J 2009 0.77
187 Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. Circ J 2005 0.77
188 Assessment of elevation of and rapid change in left ventricular filling pressure using a novel global strain imaging diastolic index. Circ J 2013 0.77
189 Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation. J Cardiol 2011 0.77
190 Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome. J Atheroscler Thromb 2010 0.77
191 Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure. J Cardiol 2010 0.77
192 The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and design of a 2-year study in patients initially hospitalised with acute coronary syndrome in Japan. Cardiovasc Drugs Ther 2010 0.77
193 Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging. Circ J 2008 0.77
194 Early hemodynamic performance of the trifecta bioprosthetic valve in patients with aortic valve disease. Circ J 2014 0.77
195 Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting. Atherosclerosis 2004 0.77
196 Effects of phase III cardiac rehabilitation on mortality and cardiovascular events in elderly patients with stable coronary artery disease. Circ J 2010 0.77
197 [Health-related quality of life in Japanese patients with ischemic heart disease: a multicenter cooperative investigation assessed using SF-36]. J Cardiol 2005 0.77
198 Effects of nicorandil on the cAMP-dependent Cl- current in guinea-pig ventricular cells. J Pharmacol Sci 2010 0.76
199 Skeletonization with an ultrasonic scalpel is as safe as a non-skeletonized dissection in preserving the endothelial function of the human gastroepiploic artery. Interact Cardiovasc Thorac Surg 2008 0.76
200 Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting. Lipids Health Dis 2010 0.76
201 The novel neutrophil differentiation marker phosphatidylglucoside mediates neutrophil apoptosis. J Immunol 2011 0.76
202 Effect of cardiac rehabilitation on muscle mass, muscle strength, and exercise tolerance in diabetic patients after coronary artery bypass grafting. J Cardiol 2013 0.76
203 Antioxidants and cardiovascular disease: Still a topic of interest. Environ Health Prev Med 2004 0.76
204 Temporal Trends in Clinical Outcomes Following Percutaneous Coronary Intervention in Patients with Renal Insufficiency. J Atheroscler Thromb 2016 0.76
205 Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design. Circ J 2006 0.76
206 Metabolic syndrome. J Atheroscler Thromb 2013 0.76
207 Relation between serum lipoprotein (a) and residual lesion stenosis of coronary artery after myocardial Infarction without reperfusion therapy. Jpn Heart J 2004 0.76
208 Effect of probucol on neointimal thickening in a stent porcine restenosis model. Jpn Heart J 2004 0.76
209 Increased circulating soluble LR11 in patients with acute coronary syndrome. Clin Chim Acta 2012 0.76
210 Impact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention. Int Heart J 2006 0.76
211 Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery. Circ J 2005 0.76
212 Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism 2002 0.76
213 Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting. Atherosclerosis 2011 0.76
214 Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Cardiovasc Ther 2013 0.75
215 Acute Myocardial Infarction with Severe ST Segment Elevation Treated with Percutaneous Coronary Intervention More than Two Days after Onset: A Case with Remarkable Recovery. Int J Angiol 2011 0.75
216 The relationship between high red blood cell distribution width and low coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Anadolu Kardiyol Derg 2014 0.75
217 Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography. Ann Clin Biochem 2012 0.75
218 Letter by Watada et al regarding article, "Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesion". Circulation 2008 0.75
219 Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm. BMJ Case Rep 2013 0.75
220 Enormous Pedunculated Vegetation Originating in the Left Ventricular Apex in a Patient with Infective Endocarditis. Intern Med 2016 0.75
221 Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J). BMC Cardiovasc Disord 2006 0.75
222 Massive Pericardial Effusion in a Case of Acute Pericarditis with Slight ST-Segment Elevation of Short Duration. Int J Angiol 2011 0.75
223 Cardiorespiratory fitness and the incidence of type 2 diabetes: a cohort study of Japanese male athletes. BMC Public Health 2014 0.75
224 T-type ca(2+) channel blockers increase smooth muscle progenitor cells and endothelial progenitor cells in bone marrow stromal cells in culture by suppression of cell death. Ann Vasc Dis 2010 0.75
225 Racial Differences in the Cholesterol-Lowering Effect of Statin. J Atheroscler Thromb 2016 0.75
226 Clinical significance of mild lipid-lowering by statins for prevention of cardiovascular disease in Japanese high-risk patients. Circ J 2010 0.75
227 Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010. Intern Med 2017 0.75
228 Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J). Cardiovasc Drugs Ther 2009 0.75
229 Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention. Circ J 2016 0.75
230 Significance of Coronary Artery Disease and Left Ventricular Afterload in Unoperated Asymptomatic Aortic Stenosis. Circ J 2015 0.75
231 Other high-risk conditions. J Atheroscler Thromb 2013 0.75
232 Statements. J Atheroscler Thromb 2014 0.75
233 [Complications related to procedures for acute coronary syndrome]. Nihon Rinsho 2006 0.75
234 [Selective coronary angiography]. Nihon Rinsho 2011 0.75
235 Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Int Immunol 2007 0.75
236 Syncope due to paroxysmal complete atrioventricular block in a patient with aortic valve stenosis. Intern Med 2014 0.75
237 [Therapeutic guidelines for heart failure]. Nihon Naika Gakkai Zasshi 2005 0.75
238 [Ischemic heart disease]. Nihon Rinsho 2010 0.75
239 Bradyarrhythmias may induce central sleep apnea in a patient with obstructive sleep apnea. Heart Vessels 2014 0.75
240 Left atrial myxoma incidentally discovered on transesophageal echocardiography. Intern Med 2015 0.75
241 Higher Hemoglobin A1c After Discharge Is an Independent Predictor of Adverse Outcomes in Patients With Acute Coronary Syndrome　- Findings From the PACIFIC Registry. Circ J 2016 0.75
242 [Diagnosis and treatment of stable effort angina pectoris]. Nihon Rinsho 2011 0.75
243 Absolute risk of cardiovascular disease and lipid management targets. J Atheroscler Thromb 2013 0.75
244 Tracheal stenosis caused by severe tortuosity of the brachiocephalic artery. Geriatr Gerontol Int 2015 0.75
245 Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittelforschung 2007 0.75
246 Noninvasive Computed Tomography-Derived Fractional Flow Reserve Based on Structural and Fluid Analysis: Reproducibility of On-site Determination by Unexperienced Observers. J Comput Assist Tomogr 2017 0.75
247 Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. J Atheroscler Thromb 2013 0.75
248 [Positioning of PROactive and its clinical application in Japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: discussion]. Nihon Rinsho 2006 0.75
249 Elderly patients. J Atheroscler Thromb 2008 0.75
250 [Coronary artery disease]. Nihon Rinsho 2003 0.75
251 [Therapeutic strategies for atrial fibrillation]. Nihon Naika Gakkai Zasshi 2007 0.75
252 Women. J Atheroscler Thromb 2008 0.75
253 [Treatment for coronary artery disease patients with impaired glucose tolerance]. Nihon Rinsho 2005 0.75
254 Evaluation of myocardial triglyceride accumulation assessed on 1H-magnetic resonance spectroscopy in apparently healthy Japanese subjects. Intern Med 2015 0.75
255 [Eessential hypertension]. Nihon Rinsho 2005 0.75
256 Large bilateral isolated internal iliac artery aneurysms. Intern Med 2012 0.75
257 [Clinical trials in coronary disease]. Nihon Rinsho 2003 0.75
258 Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy. Int Heart J 2016 0.75
259 Esophageal ulcer of unknown origin complicated by left atrial myxoma. Intern Med 2015 0.75
260 [The impact of disaster-induced stress on coronary artery disease]. Nihon Rinsho 2016 0.75
261 Long-term effect of metabolic syndrome with and without diabetes mellitus on coronary revascularization in Japanese patients undergoing percutaneous coronary intervention. Clin Cardiol 2011 0.75
262 Treatment--drug therapy. J Atheroscler Thromb 2008 0.75
263 Echocardiographic assessment of the effects of mitral valve repair on mitral valve geometry in rheumatic mitral stenosis. J Heart Valve Dis 2010 0.75
264 What is the optimal increase in resting heart rate with low dose isoproterenol infusion for tilt-induced vasovagal response? J Cardiovasc Pharmacol 2003 0.75
265 Manifestation of Brugada syndrome after pacemaker implantation in a patient with sick sinus syndrome. J Cardiovasc Electrophysiol 2004 0.75
266 Impact of initial degree of coronary narrowing on left ventricular function in first myocardial infarction. Int Heart J 2010 0.75
267 Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris. Int Heart J 2006 0.75
268 Coronary artery fistula with giant aneurysm. J Card Surg 2012 0.75
269 Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial. Heart 2012 0.75
270 Intravascular ultrasound assessment of atherosclerotic plaque in the aorta. Int J Cardiol 2007 0.75
271 The high molecular weight adiponectin level is associated with the atherogenic lipoprotein profiles in healthy Japanese males. J Atheroscler Thromb 2014 0.75
272 [Mitral stenosis associated with heart failure]. Nihon Rinsho 2007 0.75
273 Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting. Jpn Heart J 2002 0.75
274 Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients. Circ J 2008 0.75
275 [Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo Medical University]. Nihon Naika Gakkai Zasshi 2012 0.75
276 String-sign in left internal thoracic artery is associated with regression in left main trunk stenosis after coronary artery bypass. Int Heart J 2011 0.75
277 Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study. J Atheroscler Thromb 2010 0.75
278 Evaluation of the heart and great vessel calcification by conventional computed tomography in hemodialysis patients. Ren Fail 2007 0.75
279 [Optimal medical therapy in diabetic patients with coronary artery disease]. Nihon Rinsho 2016 0.75
280 Propensity analysis of 12 years outcome after bypass graft or balloon angioplasty in patients with multivessel coronary artery disease. J Cardiol 2008 0.75
281 Reactive Arthritis Caused by Urinary Tract Infection. Intern Med 2016 0.75
282 Relationship between 24-h Holter recordings and clinical outcomes in patients with permanent atrial fibrillation. J Cardiol 2012 0.75
283 Successful Management of a Patient with Refractory Ventricular Fibrillation (VF) due to Acute Myocardial Infarction (AMI) and Lung Injury by Transition from Percutaneous Cardiopulmonary Support (PCPS) to Veno-Venous Extracorporeal Membrane Oxygenation (ECMO). Intern Med 2016 0.75
284 Acute heart failure due to mitral regurgitation responding dramatically to carperitide (hANP): a case report. Int J Cardiol 2007 0.75
285 Chronic kidney disease. J Atheroscler Thromb 2013 0.75
286 Prevalence of the Brugada-type electrocardiogram and incidence of Brugada syndrome in patients with sick sinus syndrome. Circ J 2009 0.75
287 [Series: Clinical study from Japan and its reflections: introduction and summary of results: the ESTABLISH study]. Nihon Naika Gakkai Zasshi 2011 0.75
288 [Lipoprotein fractions and metabolism]. Nihon Rinsho 2007 0.75
289 Calcified plaque rupture and very late stent thrombosis after bare-metal stent implantation. Cardiovasc Interv Ther 2011 0.75
290 The elderly. J Atheroscler Thromb 2013 0.75
291 [JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome)]. Nihon Rinsho 2016 0.75
292 [Prevention of recurrence of acute coronary syndrome]. Nihon Naika Gakkai Zasshi 2004 0.75
293 [Diagnosis and treatment of acute coronary syndrome]. Nihon Naika Gakkai Zasshi 2005 0.75
294 Primary hyperlipidemia. J Atheroscler Thromb 2008 0.75
295 [Ischemic heart disease]. Nihon Rinsho 2007 0.75
296 Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study. Atherosclerosis 2012 0.75
297 Severe infundibular pulmonary stenosis and coronary artery stenosis with ventricular tachycardia 24 years after mediastinal irradiation. Intern Med 2005 0.75
298 Aortic and mitral valvular calcification in patients undergoing hemodialysis for 10 years or more and their prognosis. Int J Cardiol 2012 0.75
299 Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression. J Atheroscler Thromb 2017 0.75
300 Comparing outcomes after off-pump coronary artery bypass versus drug-eluting stent in diabetic patients. J Cardiol 2012 0.75
301 Bare Metal Stent for a Coronary Artery Aneurysm. Intern Med 2016 0.75
302 Some unanswered questions in re-stenosis prevention research. J Atheroscler Thromb 2005 0.75
303 Atrioventricular block during atrioventricular nodal reentrant tachycardia is not always benign. Jpn Heart J 2003 0.75
304 Bag-valve-mask ventilation with airway adjuncts improves neurological outcomes of in-hospital cardiac arrest. Intern Med 2012 0.75
305 [Series: Emmergency medical care Physicians are needed; MECC (Japanese Medical Emergency Care Course): Current status and future perspective]. Nihon Naika Gakkai Zasshi 2014 0.75
306 Ischemic Cardiomyopathy with a Rapid Progression from Thrombotic Thrombocytopenic Purpura. Intern Med 2015 0.75
307 Impact on Clinical Outcomes of Periodic Leg Movements During Sleep in Hospitalized Patients Following Acute Decompensated Heart Failure. Circ J 2017 0.75
308 Slightly Elevated BMI Within Normal Limits At Young Age Predict Metabolic Disorders In Japanese Men: 851 Board #167 June 1, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc 2016 0.75
309 Higher baseline LDL-C levels amplify the short-term benefit of early intensive statin treatment in acute coronary syndrome. J Atheroscler Thromb 2010 0.75
310 Cerebrovascular diseases. J Atheroscler Thromb 2013 0.75
311 APPROACH-J study: design, rationale, and baseline data of the affirmation primary prevention with pravastatin in reduction of occlusive atherosclerotic complications in hypercholesterolemia--Japan study. J Atheroscler Thromb 2011 0.75
312 Low Serum Levels of EPA are Associated with the Size and Growth Rate of Abdominal Aortic Aneurysm. J Atheroscler Thromb 2017 0.75
313 Long-term efficacy of pravastatin therapy in diabetic patients undergoing complete coronary revascularization. J Atheroscler Thromb 2010 0.75
314 Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention. J Atheroscler Thromb 2017 0.75
315 Dislodgment of an atrial screw-in pacing lead 10 years after implantation. Pacing Clin Electrophysiol 2004 0.75
316 Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease. Future Cardiol 2005 0.75
317 [Treatment of hypertension]. Nihon Rinsho 2012 0.75